Kelley Anne Saia, MD

Assistant Professor, Obstetrics & Gynecology

Kelley Saia
85 E. Concord St


Expertise includes: Treatment of substance use disorders in pregnancy and post-pregnancy, including opioid, alcohol, stimulant and marijuana use disorders; Trauma-informed care for pregnant persons with substance use disorder


  • University of Vermont, MD
  • Georgetown University, BSN
  • Hobart and William Smith Colleges, BA


  • Published on 9/20/2023

    Deflorimonte C, Glissendorf V, Hofer J, Cai A, Iannella N, Boateng JO, Carter G, Saia KA, Jones HE, Wachman EM. National Provider Survey: Use of Naltrexone for Pregnant Individuals with Substance Use Disorders. J Addict Med. 2023 Sep 20. PMID: 37729010.

    Read at: PubMed
  • Published on 6/3/2023

    Wanar A, Saia K, Field TA. Accelerated Fentanyl Metabolism During Pregnancy and Impact on Prenatal Drug Testing. Matern Child Health J. 2023 Nov; 27(11):1944-1948. PMID: 37269392.

    Read at: PubMed
  • Published on 5/19/2023

    Holland E, Gibbs L, Spence NZ, Young M, Werler MM, Guang Z, Saia K, Bateman BT, Achu R, Wachman EM. A comparison of postpartum opioid consumption and opioid discharge prescriptions among opioid-naïve patients and those with opioid use disorder. Am J Obstet Gynecol MFM. 2023 Aug; 5(8):101025. PMID: 37211090.

    Read at: PubMed
  • Published on 1/9/2023

    Laks J, Walley AY, Bagley SM, Barber CM, Gaeta JM, Neville LA, Peterkin AF, Rosenthal E, Saia KA, Weinstein ZM, Harris MTH. Developing a Women's Health track within addiction medicine fellowship: reflections and inspirations. Addict Sci Clin Pract. 2023 Jan 09; 18(1):3. PMID: 36617557.

    Read at: PubMed
  • Published on 8/17/2022

    Wanar A, Saia K, Field T. Predictors of the Rate of Illicit Fentanyl Metabolism in a Cohort of Pregnant Individuals. J Addict Med. 2023 Jan-Feb 01; 17(1):85-88. PMID: 35972138.

    Read at: PubMed
  • Published on 8/17/2022

    Wanar A, Isley BC, Saia K, Field TA. False-positive Fentanyl Urine Detection after Initiation of Labetalol Treatment for Hypertension in Pregnancy: A Case Report. J Addict Med. 2022 Nov-Dec 01; 16(6):e417-e419. PMID: 35972891.

    Read at: PubMed
  • Published on 8/2/2022

    Perry BN, Vais S, Boateng JO, Jain M, Wachman EM, Saia KA. Buprenorphine-naloxone Versus Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy. J Addict Med. 2022 Nov-Dec 01; 16(6):e399-e404. PMID: 35916423.

    Read at: PubMed
  • Published on 1/1/2022

    Harris MTH, Laks J, Stahl N, Bagley SM, Saia K, Wechsberg WM. Gender Dynamics in Substance Use and Treatment: A Women's Focused Approach. Med Clin North Am. 2022 Jan; 106(1):219-234. PMID: 34823732.

    Read at: PubMed
  • Published on 11/1/2021

    Komaromy M, Tomanovich M, Taylor JL, Ruiz-Mercado G, Kimmel SD, Bagley SM, Saia KM, Costello E, Park TW, LaBelle C, Weinstein Z, Walley AY. Adaptation of a System of Treatment for Substance Use Disorders During the COVID-19 Pandemic. J Addict Med. 2021 Nov-Dec 01; 15(6):448-451. PMID: 33298750.

    Read at: PubMed
  • Published on 7/1/2021

    Harris M, Joseph K, Hoeppner B, Wachman EM, Gray JR, Saia K, Wakeman S, Bair-Merritt MH, Schiff DM. A Retrospective Cohort Study Examining the Utility of Perinatal Urine Toxicology Testing to Guide Breastfeeding Initiation. J Addict Med. 2021 Jul-Aug 01; 15(4):311-317. PMID: 33060464.

    Read at: PubMed

View 25 more publications: View full profile at BUMC

View all profiles